SUNITINIB MALATE 50MG CAPSULES — Siddhi Pharma
ISO 9001:2015 Certified Support
Home Products Cancer Care SUNITINIB MALATE 50MG CAPSULES
Cancer Care SKU: SP-02187

SUNITINIB MALATE 50MG CAPSULES

Price
Price on Request

Sunitinib Malate 50 mg Capsules are prescription targeted anticancer medicines used to treat certain cancers, including advanced renal cell carcinoma (kidney cancer), gastrointest…

Strength 50 mg
Brand SUTENAMO 50 MG
Packaging Size Bottle of 28 CAPSULES
Category Cancer Care
Stock 0 units
100% Genuine
Fast Delivery
Quality Assured

Short Description

Sunitinib Malate 50 mg Capsules are prescription targeted anticancer medicines used to treat certain cancers, including advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and progressive pancreatic neuroendocrine tumors (pNET). Sunitinib works by inhibiting specific protein kinases involved in tumor growth and the formation of new blood vessels.

Full Details

Sunitinib Malate 50 mg Capsules are oral targeted anticancer medicines belonging to the tyrosine kinase inhibitor class. They inhibit multiple receptor tyrosine kinases involved in tumor cell proliferation, angiogenesis, and cancer progression.

Sunitinib is used in eligible adults with advanced renal cell carcinoma, unresectable or metastatic gastrointestinal stromal tumors following failure or intolerance to imatinib, and progressive, well-differentiated pancreatic neuroendocrine tumors that cannot be surgically removed or have spread. Treatment should be prescribed and monitored by an oncologist, with appropriate monitoring of blood counts, liver function, blood pressure, and other potential adverse effects.

Composition

Sunitinib Malate equivalent to Sunitinib 50 mg per capsule.

Shipping Information

We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.

Loading...